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Available online 14 October 2016West Nile Virus (WNV) is a mosquito-transmitted virus from the Flaviviridae family that causes fever in 1 in 5
infected people.WNV can also become neuro-invasive and cross the blood-brain barrier leading to severe neuro-
logical symptoms in a subset of WNV infected individuals [1]. WNV neuro-invasion is believed to be inﬂuenced
by a number of factors including host genetics. In order to explore these effects and recapitulate the complex
immune genetic differences among individuals, we studied gene expression followingWNV infection in the Col-
laborative Cross (CC)model. The CC is amouse genetics resource composed of N70 independently bred, octo-pa-
rental recombinant inbredmouse lines [2]. To identify the individual host gene expression signatures inﬂuencing
protection or susceptibility toWNVdisease andWNVneuroinvasion, we used the nanostring nsolver platform to
quantify gene expression in brain tissue isolated from WNV-infected CC mice at days 4, 7 and 12 post-infection
[3]. This nanostring technologyprovided a high throughput, non-ampliﬁcation basedmRNAquantitationmethod
to detect immune genes involved in neuro-invasion. Data was deposited into the Gene Expression Omnibus
(GEO) under accession GSE85999.ss article under the CC BY license (htPublished by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
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mple source location Seattle, WA, USASa1. Direct link to deposited data
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE859992. Experimental design
We screened RNA from 95 brain samples across 8 unique CC dRIX
(collaborative cross discovery recombinant intercrosses), F1 crosses of
the CC recombinant inbred lines (see Table 1). Across the 8 CC dRIX,
four were symptomatic and four were asymptomatic following infec-
tion. Samples were collected on days 4, 7, and 12 post-WNV infection.
The nanostring platform uses the ncounter technology that utilizes
100 nt molecular bar codes (50 nt capture probe and 50 nt reporter
probe) which measure gene quantities without an ampliﬁcation step.
We used a predesigned kit (pan cancer immune) that includes 770 im-
mune related genes.3. Material and methods
3.1. Virus
West Nile virus TX-2002-HC (WN-TX) was grown using previously
described methods [4]. Viral stocks were generated using supernatants
collected from infected Vero cell lines and stored at 80 °C.tp://creativecommons.org/licenses/by/4.0/).
Table 1
Summary of collaborative cross samples.
CC dRIX WNV in CNS Tissue Timepoints
CC11/Unc_x_CC042/GeniUNc Asymptomatic (no WNV) Brain D4, D7, D12
CC008/Geni_x_CC010/GeniUnc Asymptomatic (no WNV) Brain D4, D7, D12
CC031/GeniUnc_x_CC017/Unc Asymptomatic + WNV Brain D4, D7, D12
CC039/Unc_x_CC020/GeniUnc Asymptomatic + WNV Brain D4, D7, D12
CC016/GeniUnc_x_CC038/GeniUnc Symptomatic + WNV Brain D4, D7, D12
CC043/GeniUnc_x_CC037/TauUnc Symptomatic + WNV Brain D4, D7, D12
CC061/GeniUnc_x_CC026/GeniUnc Symptomatic + WNV Brain D4, D7, D12
CC038/GeniUnc_x_CC013/GeniUnc Symptomatic + WNV Brain D4, D7, D12
Fig. 1.Genomic analysis in CollaborativeCross brain tissue. A heatmap showinggene co-expression data across theCC-dRIXpanel (Fig. 1). RNAwas extracted from tissue isolated at days 4,
7, and 12 post-WNV infection, processed for nanostring, and differential expression assessed (relative tomock day 2). Table 1 shows the different genetic backgrounds of the CC-dRIX and
their outcomes after exposure toWNV. CC dRIXs are sorted by disease pathogenic phenotype (asymptomatic dRIXs displayed no signiﬁcant increase in clinical scores or weight loss, and
fully recovered; symptomatic CC dRxs displayed increase in clinical scores, weight loss, and in some cases succumbed to infection). Genes are clustered by co-expressed modules (color
blocks, Y-axis); identities in Table 2, see 3.7 co-expression).
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Table 2
Identiﬁers and phenotypes for CC dRIXs (collaborative cross discovery recombinant
intercrosses).
CC dRIX CC dRIX2 WNV in CNS
CC11/Unc_x_CC042/GeniUNc 3252 × 8042 Asymptomatic (no WNV)
CC008/Geni_x_CC010/GeniUnc 8036 × 18018 Asymptomatic (no WNV)
CC031/GeniUnc_x_CC017/Unc 8002 × 3032 Asymptomatic + WNV
CC039/Unc_x_CC020/GeniUnc 15155 × 8054 Asymptomatic + WNV
CC016/GeniUnc_x_CC038/GeniUnc 8024 × 8049 Symptomatic + WNV
CC043/GeniUnc_x_CC037/TauUnc 8021 × 16072 Symptomatic + WNV
CC061/GeniUnc_x_CC026/GeniUnc 8048 × 8026 Symptomatic + WNV
CC038/GeniUnc_x_CC013/GeniUnc 8049 × 8010 Symptomatic + WNV
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CC dRIX lineswere bred at the University of North Carolina at Chapel
Hill under speciﬁc-pathogen-free (SPF) conditions. Male mice were
transferred to the University of Washington at 6 to 8 weeks old. Age-
and sex-matched 8- to 10-week old mice were subcutaneously inocu-
lated in the rear footpad with 100 PFU WN-TX. Mice were monitored
daily for morbidity (percentage of initial weight loss) and clinical dis-
ease scores. Mice were housed under BSL-3 conditions throughout the
experiments, and tissues were processed under BSL-3 conditions. All
animal experimentswere approved by theUniversity ofWashington In-
stitutional Animal Care andUseCommittee. TheOfﬁce of LaboratoryAn-
imalWelfare of theNational Institutes of Health (NIH) has approved the
University ofWashington (A3464-01), and this studywas carried out in
strict compliance with the Public Health Service (PHS) Policy on Hu-
mane Care and Use of Laboratory Animals.
3.3. Collaborative Cross dRIX lines and disease deﬁnitions
The clinical scoring system used to evaluateWNV-infectedmicewas
as follows: 0, healthymouse (baseline); 1, rufﬂed fur, lethargy, hunched
posture, no paresis, normal gait; 2, altered gait, limited movement in
one hind limb; 3, lack of movement, paresis in one or both hind limbs;
4, moribund. Based on weight loss, clinical scoring, and brain histology,
CC dRIXswere segregated into two broad categories: asymptomatic and
symptomatic. We evaluated all lines for evidence of WNV within theFig. 2.Molecular bar codes show elevation in Abcb1a and Tie1. The gene counts (from themole
genes in the nanostring panel. This standardnormalization approachwas able to identify small i
increases in the symptomatic line.CNS by qPCR. Symptomatic lines were deﬁned by having weight loss
N10% and/or any death, whereas asymptomatic were deﬁned by having
a b10% weight loss and no death. CNS histopathologic involvement was
evaluated by a veterinary pathologist. The CC dRIX featured in this study
are listed in Table 1.
3.4. RNA extraction and quantitative PCR (qPCR) of WNV
Brain tissue from mock or WNV-infected mice were stored and ho-
mogenized in PBS at 5500 RPM using a Precellys 24 machine. Samples
were then transferred into tubes containing TRI Reagent. Total RNA
was extractedusing theRibopure RNAPuriﬁcation Kit,with the addition
of bromochloropropane. RNA was converted to cDNA using the iScript
Select cDNA Synthesis Kit (Biorad). cDNAwas assayed forWNV expres-
sion through relative expression SYBR Green RT-qPCR, with GAPDH as a
loading control.
3.5. Nanostring analysis
Nanostring results (raw and normalized counts) were produced
from RCC ﬁles using the nSolver software (version 2.6). Raw comma
delimited ﬁles will be exported and uploaded to Rstudio (version
0.99.486) with R (version 3.2.4). Over 95% of the genes on the
nanostring panel matched to previous probe matching techniques [8].
Exploratory analysis and summary statistics were calculated to identify
variations in the data and relationships among replicates and conditions
in each study.
3.6. Statistical modeling
We assessed the nanostring data using two statistical approaches. In
one approach, we normalized the expression data using pre-selected,
internal housekeeping genes and plotted subsets of immune related
genes in spotﬁre (Fig. 2). In an alternate approach, we performed differ-
ential expression analysis across all genes from ﬁltered gene counts
(mean ≥ 20) and then normalized the raw counts using the voom
Bioconductor package in limma. Linear modeling was then performed
in limma using R [1,6,7].cular bar codes) were averaged across replicates and normalized to internal housekeeping
ncreases inAbcb1a and Tie1within the brain tissue from an asymptomatic line and gradual
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Co-expression was only performed on those genes that were deter-
mined to be statistically signiﬁcant from the differential expression
analysis (threshold: log2 fold change ≥ | 0.58 | and FDR ≤ 0.05) in at
least one comparison (Mock vs. Infected at days 2, 4, 7 and 12 post-in-
fection). Pearson correlations were run on the union of log2FC using
the WGCNA (color modules) and heatmap.2 Bioconductor packages in
R [1,6,7].
3.8. Functional analysis
Ingenuity Pathway Analysis (IPA) and Jepetto (version 1.3.1) were
used to determine the biological functions of modules in the co-expres-
sion analysis. These tools accept a list of genes and produce a list of
known biological functions with an enrichment score corresponding
to how signiﬁcant those genes are to each function.
4. Conclusion
Differential expression analysis of the brain tissue fromWNV-infect-
ed CC dRIX lines identiﬁed several hundred (523) up-regulated, statisti-
cally signiﬁcant genes, primarily in CC lines that were symptomatic for
disease and qPCR positive for WNV expression in the brain (CC043/
GeniUnc_x_CC037/TauUnc, CC016/GeniUnc_x_CC038/GeniUnc, CC061/
GeniUnc_x_CC026/GeniUnc, CC038/GeniUnc_x_CC013/GeniUnc). Co-
expression analysis revealed large differences in the genetic signatures
between those animals that were asymptomatic and those developing
neuro-invasive WNV infection. The asymptomatic lines showed strong
early activation of innate immune genes associated with the RIG-I-like
Receptor (RLR) pathway. Only animals deﬁned as asymptomatic
showed an increase in expression at day 4 and day 7 post-infection
with WNV. In the asymptomatic lines where WNV was detected in the
brain, we found an elevation in genes associated with toll like receptor
signaling, antigen presentation, andnatural killer cellmediated cytotox-
icity at days 7 and 12 post-WNV infection. In the symptomatic animals,
themost gene expression occurred at day 12 post-infection, a timepoint
when signiﬁcant levels ofWNVweredetected in the brain. The brain tis-
sue isolated from symptomatic animals also demonstrated activation of
the innate immune signaling pathways, but unlike the symptomatic
lines, the increase in gene activity was sustained throughout the time
course, up to day 12 post-infection.
From looking at unique gene activation in CC039/Unc_x_CC020/
GeniUnc within the panel, we observed slight increases in genes
Abcb1a and Tie1. Abcb1a is part of the family of (ABC) transporters pro-
teins that facilitate the transport molecules across intra and extra cellu-
lar membranes. Abcb1a also plays a role in antigen presentation and is
involved in the permeability of the blood brain barrier with certain hy-
drophobic amphipathic drugs. Tie1 (Tyrosine kinase with immunoglob-
ulin-like and EGF-like domains 1) is a gene involved in endothelial cell
adhesion and migration through a p38 mechanism [9]. Tie1 waspreviously reported in immune studies in the CC [5] related to vascular
differentiation and endothelial activation after Ebola virus infection. In
our study, Tie2 is slightly elevated at day 7 in an asymptomatic line
with detectable WNV in the brain.
Together, these ﬁndings build upon previous studies [5] where a ge-
netic resource population (GRP) like the CC can detect key genes that
may be driving the outcome variation in a population. In summary,
the CC is emerging as a powerful resource for studying genetic variances
that determine disease susceptibility, and utilizing sensitive, high
throughput technologies, like nanostring to evaluate gene expression
in GRPs will help us improve our understanding of host responses to
pathogenic infection.
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